Overview
Jonathan Lambird is a Hematologist Oncology specialist and a Hematologist in Winston Salem, North Carolina. Dr. Lambird is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Smoldering Multiple Myeloma, and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Lambird is currently accepting new patients.
His clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Medical Ctr Blvd, Winston Salem, NC 27157
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Wake Forest University Health Sciences
John Mckay is a Hematologist Oncology specialist and a Hematologist in Winston Salem, North Carolina. Dr. Mckay is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant. Dr. Mckay is currently accepting new patients.
Martinsville Physician Practices LLC
Owen Roberts is a Hematologist Oncology specialist and a Hematologist in Martinsville, Virginia. Dr. Roberts is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Neuroendocrine Tumor, Angiosarcoma, Breast Cancer, and Paget Disease of the Breast. Dr. Roberts is currently accepting new patients.
Patricia Zekan is an Oncologist and a Hematologist Oncology provider in Winston Salem, North Carolina. Dr. Zekan is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Paget Disease of the Breast, Multiple Myeloma, and Schnitzler Syndrome. Dr. Zekan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Lambird isDistinguished. Learn about Multiple Myeloma.
- Schnitzler SyndromeDr. Lambird isDistinguished. Learn about Schnitzler Syndrome.
- Advanced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Relapsed Refractory Multiple Myeloma (RRMM)
- Smoldering Multiple MyelomaDr. Lambird isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Lambird isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Lambird isExperienced. Learn about Adrenal Cancer.
- Childhood Acute Myeloid LeukemiaDr. Lambird isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Lambird isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).